Dosage Regimen: Individualization
Analysis of Population Pharmacokinetic Data
Comparing Copy Number Variations and SNPs
Genome-wide Association Studies-GWAS
Bioequivalence Data: Statistical Interpretation
Genetic Variation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 2, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Sally Luvsantseren1, Michelle Whirl-Carrillo2, Katrin Sangkuhl2
1Department of Pharmacy, Stanford Health Care, Stanford, CA 94305, USA.
Commercial pharmacogenetic testing companies show significant variability in gene panels and variant screening. This leads to discordant phenotype reporting, causing patient distress and highlighting the need for industry-wide consensus.
Area of Science:
Background:
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016